Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8234971 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 9 Pages |
Abstract
Nearly all radiation oncologists report following the evidence-based recommendation of chemoradiation for young, otherwise healthy patients with locally advanced, unresectable NSCLC, but there is substantial variability in treatment recommendations for older or sicker patients, probably related to the lack of clinical trial data for such patients. The physician and practice characteristics we examined only weakly affected treatment recommendations. Additional clinical trial data are necessary to guide recommendations for treatment of elderly patients and patients with poor pulmonary function to optimize their management.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Irwin H. M.D., Ph.D., James A. M.D., M.B.A., Mary Beth Ph.D., Joel M.D., May Lin M.D., M.S., Karyn A. M.D., Nancy L. M.D., M.P.H.,